This is an observer-blinded, three-arms study in 376 patients in Chinese individuals aged from 18 to 55 years old who had previously received three doses COVID-19 vaccine. Immunogenicity in terms of ...

Assessing immunogenicity is a cornerstone of modern drug development, especially for biologics and vaccines. Understanding how the immune system interacts with therapeutic agents is essential to ...

Scientists working for Novartis have taken a step forward in better understanding how new classes of biological drugs might affect patients’ immune systems. Paul Wassmann, PhD senior principal ...

In a recent study published in Scientific Reports, researchers characterized the immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species responsible for Nipah ...

Maternal immunization has emerged as a critical public health strategy to protect both pregnant women and their offspring from vaccine-preventable diseases, ...

The Phase I/II study will enrol approximately 368 adults aged 18 years and above.